Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Cholesterol Medication Recalls

Recalls of statins and other lipid-lowering drugs used to manage high cholesterol.

161 recalls in this category, newest first.

Class II · Moderate risk

Simvastatin Tablets

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Accord Healthcare, Inc. NDC 16729-004-15 D-0409-2023
Class II · Moderate risk

Rosuvastatin Tablets

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Accord Healthcare, Inc. NDC 16729-287-10 D-0407-2023
Class II · Moderate risk

Rosuvastatin Tablets

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Accord Healthcare, Inc. NDC 16729-286-15 D-0406-2023
Class II · Moderate risk

Rosuvastatin Tablets

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Accord Healthcare, Inc. NDC 16729-285-15 D-0405-2023
Class II · Moderate risk

Rosuvastatin Tablets

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Accord Healthcare, Inc. NDC 16729-284-15 D-0404-2023
Class II · Moderate risk

Ezetimibe and Simvastatin Tablets

Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity

Terminated Failed specification Golden State Medical Supply Inc. NDC 51407-193-05 D-0228-2022
Class II · Moderate risk

Ezetimibe and Simvastatin Tablets

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Terminated Particulate / foreign matter Golden State Medical Supply Inc. D-0227-2022
Class II · Moderate risk

Dr. Reddy's Ezetimibe and Simvastatin Tablets

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Terminated Particulate / foreign matter Dr. Reddy's Laboratories, Inc. NDC 43598-743-05 D-0085-2022
Class III · Low risk

Atorvastatin Calcium Tablets

Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-121-05 D-0629-2021
Class III · Low risk

Atorvastatin Calcium Tablets

Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-121-05 D-0599-2021
Class II · Moderate risk

Fenofibrate Capsules

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. D-0407-2021
Class III · Low risk

Atorvastatin Calcium Tablets

Failed Impurities/Degradation Specifications:presence of ATV cyclo IP and FP, Dihydroxy epoxy and Dieto epoxy impurities

Terminated Impurity / degradation Dr. Reddy's Laboratories, Inc. NDC 55111-123-90 D-0291-2021
Class II · Moderate risk

Simvastatin Tablets

CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Terminated Packaging defect Aurobindo Pharma USA Inc. NDC 65862-053-90 D-1234-2020
Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.

Terminated Particulate / foreign matter Sun Pharmaceutical Industries, Inc. NDC 63304-829-05 D-1047-2020
Class II · Moderate risk

Caduet (amlodipine besylate/atorvastatin calcium)

Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.

Terminated Packaging defect Pfizer Inc. NDC 0069-2160-30 D-0842-2020